US Food and Drug Administration (USFDA) has commenced inspection at Indoco Remedies’ Goa Plant I (Solid oral facility) since January 17, 2019. Inspection of Goa Plant II (Sterile facility) was completed from November14- 21, 2018.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.